June 22, 2018
Joint Commission seeking comments on anticoagulation NPSG
Editor's Note
The Joint Commission announced on June 20 that it is seeking comments on proposed changes to the National Patient Safety Goal (NPSG) 03.05.01 on reducing harm from anticoagulant therapy.
Revised requirements, which will address the use of new direct oral anticoagulant medications, include:
- drug selection
- dosing and monitoring
- bleeding reversal
- perioperative management
- adverse drug events.
Comments will be accepted through July 31, 2018.
Free Daily News
- Survey assesses continued impact of Change Healthcare cyberattack
- WHO sounds alarm on potential spread of bird flu
- Allison Massari to deliver hopeful, empowering keynote address at OR Manager Conference 2024
- Neurosurgery trial: Early evacuation improves long-term hemorrhage outcomes
- Drug shortages higher than ever
- FDA announces class 1 recalls for premixed embolic, infusion pump software
- Academic medical centers identify performance-improvement priorities
- Propofol anesthesia for colonoscopy could help find polyps, prevent cancer
- FDA Class 1 recall renews concern about historically problematic heart pumps
- New physician compensation report reveals modest pay gains but growing discontent with the profession
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity, Equity, Inclusion & Belonging